Home › Trial NCT03358004
the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment
- Trial IDNCT03358004
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorMario Negri Institute for Pharmacological Research
- Enrollment4
- Start date2017-06-14
- ConditionsTriple Negative Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.